Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1345, 2002-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Paclitaxel plus cisplatin increases survival, costs in ovarian cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. :
Paclitaxel plus cisplatin and lonidamine showed `good activity' in advanced ovarian cancer
Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. :
Paclitaxel vs cyclophosphamide, + cisplatin, for ovarian cancer
Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. :
Cisplatin plus paclitaxel superior in cervical cancer?
Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. :